Ian Taylor - Feb 23, 2024 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Scientific Officer
Signature: /s/ Jared Freedberg, as attorney-in-fact for Ian Taylor
Stock symbol: ARVN
Transactions as of: Feb 23, 2024
Transactions value $: -$80,032
Form type: 4
Date filed: 2/27/2024, 06:33 PM
Previous filing: Jan 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Award	$0	+39.3K	+35.69%	$0.00	149K	Feb 23, 2024	Direct	F1
transaction	ARVN	Common Stock	Sale	-$80K	-1.7K	-1.14%	$47.05	148K	Feb 23, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARVN	Stock Option (right to buy)	Award	$0	+58.1K		$0.00	58.1K	Feb 23, 2024	Common Stock	58.1K	$47.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting in on February 23, 2026.
F2	This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3	The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.